Live Chat on The Biotech Forum has been dominated by discussion of covered call opportunities in recent quarters. To see what I and the other season biotech investors are targeting as trading ideas real-time, just initiate your free trial into The Biotech Forum by clicking HERE .Today, I am putting life sciences concern Repligen Corporation ( NASDAQ: RGEN ) in the spotlight. The company posted mixed second quarter results in late July, but management did bump up their FY2025 guidance. The stock hasBret lead ...